Since the peak of the most recent wave of COVID-19 disease in early August, Orange County has seen a steady decline in cases of COVID-19. In the last two weeks, however, there has been a flattening of the curve, with a rate still substantially higher than was seen in the...

The California Department of Public Health (CDPH) and the Orange County Health Care Agency have been receiving increased reports of disseminated gonococcal infection (DGI). DGI is an uncommon but severe complication of untreated gonorrhea. DGI occurs when the sexually transmitted pathogen Neisseria gonorrhoeae invades the bloodstream and spreads to distant...

Continue to new location.

(Santa Ana, CA) – In response to today’s approvals from the Western States Safety Review Workgroup and the California Department of Public Health (CDPH), the OC Health Care Agency (HCA) is finalizing preparations to offer the Comirnaty (Pfizer) COVID-19 vaccine to children ages 5-11. “We expect the vaccine to be...

(Santa Ana, CA) – In response to the oil spill that occurred along the Orange County coastline the weekend of October 2, OC Health Care Agency (HCA) Director and County Health Officer Dr. Clayton Chau continues to advise the public to refrain from consuming contaminated fish or seafood from affected...

(Santa Ana, CA) – On November 4, the Occupational Safety and Health Administration (OSHA) published their emergency temporary standard (ETS) to the Federal Register . The ETS establishes binding requirements to protect unvaccinated employees of large employers (100 or more employees) from the risk of contracting COVID-19 in the workplace...

FAQs Can the DUI providers change the terms of my program? No. The DUI providers can only enroll you into the program that was ordered by the court. Do I have to pay for the DUI program? Yes. All providers post their program prices in advance and will explain their...

Earlier this week, the California Department of Public Health (CDPH) released updated recommendations for medical providers for the use of anti-SARS-CoV-2 monoclonal antibodies. This guidance outlines recommendations for the use of these products for treatment and post-exposure prophylaxis. In light of current national shortages, the advisory also details the current...